Pharmabiz1m
Karnataka pharmacists upload sales & rack stock of Schedule H & K drugs to bring in transparency in medicine dispensing
Pharmacists in Karnataka have started uploading sales and rack stock of Schedule H & K drugs on the state drugs control portal to bring in transparency in medicine dispensing. By mandating this ...
Pharmabiz1m
NCCE recommends formation of expert committee to determine rates under Clinical Establishments Rules
The National Council for Clinical Establishments (NCCE) has recommended to form an expert committee comprising representatives from various stakeholders for the determination of rates as per the ...
Pharmabiz1m
MvPI releases updated version of medical devices adverse event reporting form
MvPI releases updated version of medical devices adverse event reporting form: Our Bureau, New Delhi Thursday, October 10, 2024, 08:00 Hrs [IST] The Materiovigilance Programme of ...
Pharmabiz20h
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries
ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries: London, UK Wednesday, October 9, 2024, 12:00 Hrs [IST] GSK plc announced that ...
Pharmabiz18h
GSK presents positive data from AReSVi-006 phase III trial of respiratory syncytial virus vaccine, Arexvy at CHEST 2024 annual meeting
GSK presents positive data from AReSVi-006 phase III trial of respiratory syncytial virus vaccine, Arexvy at CHEST 2024 annual meeting: London, UK Wednesday, October 9, 2024, 14:0 ...
Pharmabiz17h
ModeX Therapeutics secures $35 mn BARDA supplement to develop Covid multispecific antibodies and $16 mn to initiate influenza programme
Weston, Massachusetts Wednesday, October 9, 2024, 15:00 Hrs [IST] ...
Pharmabiz14h
Adcendo gets US FDA clearance to begin ADCElerate-01 phase I/II trial of ADCE-D01 in patients with metastatic and/or unresectable STS
Adcendo gets US FDA clearance to begin ADCElerate-01 phase I/II trial of ADCE-D01 in patients with metastatic and/or unresectable STS: Copenhagen, Denmark Wednesday, October 9, 20 ...
Pharmabiz15h
Aurigene announces phase 1 study for India’s first trial for novel autologous CAR-T cell therapy for multiple myeloma
Aurigene announces phase 1 study for India’s first trial for novel autologous CAR-T cell therapy for multiple myeloma: Our Bureau, Bengaluru Wednesday, October 9, 2024, 16:45 Hr ...
Pharmabiz16h
Ascentage Pharma gets China NMPA nod to start registrational phase III studies of APG-2449 to for treat patients with NSCLC
Rockville, Maryland Wednesday, October 9, 2024, 16:00 Hrs [IST] ...
Pharmabiz15h
NIHR and the Office for Life Sciences fund new projects to drive earlier diagnosis of cancer
The NIHR and the Office for Life Sciences (OLS) have funded six projects through NIHR's Invention for Innovation (i4i) and the OLS Cancer Programme. These six projects are receiving almost £11 million ...
Pharmabiz18h
The Roquette Foundation for Health announces the winner of its 3rd Research Prize in the field of health prevention
The Roquette Foundation for Health has awarded its 3rd Research Prize to scientist Delphine Payros and her team, for their work on the toxicity of multiple dietary exposures involving mycotoxins in ...
Pharmabiz23h
Boehringer gets US FDA breakthrough therapy designation and initiates two phase III trials in MASH for survodutide
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health., announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for ...